Ireland's Primary Care Reimbursement Service has approved Althea Group Holdings Limited's cannabis oil for reimbursement, making it free for Irish patients being treated for chemotherapy-induced nausea and vomiting. The company's subsidiary, MyAccess Clinics, will offer consultations to patients in Ireland starting in November. Earlier this month, MS Ireland confirmed that Sativex, a drug developed by GW Pharmaceuticals and now part of Jazz Pharmaceuticals, will also be reimbursed.